MapLight Therapeutics (MPLT) Treasury Shares (2024 - 2026)
MapLight Therapeutics (MPLT) posted Treasury Shares of $5.3 million for Q4 2025, down 88.28% sequentially from $45.0 million in Q3 2025, and up 53.85% YoY from $3.4 million in Q4 2024.
MapLight Therapeutics (MPLT) Treasury Shares (2024 - 2026) Analysis & Trends
MapLight Therapeutics has reported Treasury Shares for 2 years, with the latest figure at $5.3 million in Q4 2025.
- Quarterly Treasury Shares rose 53.85% year-over-year to $5.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.3 million (up 53.85% YoY) and the FY2025 annual result came in at $5.3 million, up 5.54% from the prior year.
- Treasury Shares eased to $5.3 million in Q4 2025 per MPLT's latest filing, from $45.0 million in the prior quarter.
- Over five years, Treasury Shares peaked at $147.3 million in Q3 2024 and troughed at $3.4 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | MapLight Therapeutics | 533.88 Mn | 533.88 Mn | - | 4.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.69 Mn |
| Jun 30, 2026 | 4.69 Mn |
| Dec 31, 2025 | 5.28 Mn |
| Dec 31, 2025 | 5.28 Mn |
| Sep 30, 2025 | 45.01 Mn |
| Sep 30, 2025 | 45.01 Mn |
| Dec 31, 2024 | 3.43 Mn |
| Dec 31, 2024 | 3.43 Mn |
| Sep 30, 2024 | 147.33 Mn |
| Sep 30, 2024 | 147.33 Mn |